Theragenics Corp (NYSE:TGX)

CAPS Rating: 5 out of 5

A medical device company serving the cancer treatment and surgical markets. The Company produces, markets and sells TheraSeed(r), its premier palladium-103 prostate cancer treatment device and I-Seed, its iodine-125 based prostate cancer treatment device.

Featured Broker Partners


Advertisement